|
| Human CD42a/GP9 Protein (LTP10370) |
|
| LTP10370 |
|
| 100ug |
|
|
$450 In stock |
| Filamentous M13 phage extrude from infected Escherichia coli with a tip structure composed of gp7 and gp9. This tip structure is extended by the assembly of the filament composed of the major coat protein gp8. gp7, gp8 and gp9 could also be used for phage display and these phage particles should bind to two different or more surfaces when the modified coat proteins are combined. The gp9 at the phage tip is suitable for the phage display technology. |
| Recombinant Human CD42a/GP9 Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Thr17-Gly147. |
|
| CD42a/GP9 |
|
| Human |
|
| P14770 |
|
| Thr17-Gly147 |
|
| The protein has a predicted MW of 41 kDa. Due to glycosylation, the protein migrates to 48-50 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-hFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in 20mM Tris, 250mM NaCl (pH 8.5). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
